-
HOXC8, Caspase-1, and Pyroptosis in Lung Cancer
2026-09-18
The reference study identifies HOXC8 as a transcriptional brake on caspase-1 expression and shows that its depletion triggers ASC-independent pyroptosis in non-small cell lung cancer cells. Its mechanistic model connects HOXC8 with HDAC1/2 recruitment at the CASP1 promoter, providing a framework for studying transcriptional control of inflammatory cell death and tumorigenesis.
-
Syringin N1347: Reliable Cell Assay Workflows
2026-09-18
This scenario-based guide explains how Syringin SKU N1347 can support reproducible cell viability, proliferation, cytotoxicity, and apoptosis research. It combines product-specific solubility and quality data with practical RCC assay design, interpretation, and vendor-selection guidance.
-
Carbapenemase Gene Transmission in CREC
2026-09-17
This multicenter study maps carbapenemase-encoding genes, their genetic locations, transferability, and clonal distribution in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. Its integrated approach shows that plasmid-associated blaNDM-1 and mobile genetic elements are central to multidrug resistance dissemination, while also defining the limits of phenotypic and PCR-based transmission analysis.
-
Streptozotocin Workflows for Diabetes Research
2026-09-17
Build reproducible STZ models by controlling formulation, exposure, metabolic validation, and neuropathy readouts from the outset. This workflow also shows how chemically induced β-cell injury can be connected—carefully and transparently—to microglial pyroptosis and TBK1 biology in painful diabetic neuropathy research.
-
Psora 4: Reading Kv1.3 Blockade in T Cells
2026-09-16
Psora 4 is a selective Kv1.3 blocker for connecting membrane excitability with T-cell Ca2+ signaling and effector-memory responses. This article adds a channel-architecture perspective, showing how KCNE4-dependent kinetics should shape assay interpretation and translational decisions.
-
Macrophage Reprogramming in Liver MDB Pathogenesis
2026-09-15
Fang et al. used single-nucleus RNA sequencing and complementary co-culture experiments to resolve macrophage heterogeneity during Mallory-Denk body formation in a DDC-induced mouse model. The study identifies a Gpnmb-high lipid-associated macrophage state and links hepatocyte-derived mitochondrial DNA to NLRP3 inflammasome activation, providing a framework for connecting liver injury, immune-cell remodeling, and protein aggregate pathogenesis.
-
SPOP Molecular Glue Degradation in Melanoma Immunity
2026-09-15
The reference study shows that SPOP promotes melanoma growth by recognizing and degrading STING, while SPOP inhibitors can also redirect the ligase toward CBX4 as molecular glue degraders. This dual activity increases innate immune signaling and improves responses to immune checkpoint blockade and CD19-CAR-T therapy in mouse melanoma models.
-
Foretinib Workflow for Multidimensional Cancer Assays
2026-09-14
Foretinib (GSK1363089) supports more than a single viability endpoint: it can connect Met and VEGFR pathway inhibition with tumor cell growth inhibition, motility, invasion, and metastasis studies. This workflow combines time-resolved viability and cell-death measurements with migration assays to distinguish cytostatic responses from genuine cytotoxicity.
-
Mono-ADP-Ribosylation Marks PARP7 and AHR for Degradation
2026-09-14
The reference study establishes a strategy for revealing normally transient endogenous ADP-ribosylation by blocking ubiquitin-dependent turnover. Its key finding is that DTX2 recognizes ADP-ribosylated PARP7 substrates, including PARP7 and AHR, providing a proteasome-linked mechanism that rapidly limits AHR transcriptional signaling.
-
MK-8745: Aurora A Inhibitor Workflow
2026-09-13
MK-8745 is a potent, selective Aurora A inhibitor for connecting mitotic disruption with G2/M arrest and apoptosis in cancer models. This practical guide covers formulation, cell-based assay design, retinoblastoma translation, xenograft interpretation, and troubleshooting.
-
Liproxstatin-1: A Smarter Ferroptosis Assay
2026-09-12
Liproxstatin-1 is a potent ferroptosis inhibitor for separating lipid peroxidation-driven death from apoptosis and nonspecific oxidative injury. This article develops a sex-aware, mechanism-first assay strategy inspired by a 2025 salivary-gland study.
-
Medial Septum Control of Hippocampal Splitter Cells
2026-09-12
Li et al. show that hippocampal splitter cells multiplex contextual inputs and response information during conditional discrimination learning. The study further identifies medial septum parvalbumin-expressing neurons as a circuit component that selectively supports contextual representations required for accurate associative behavior.
-
Mildronate Lipidoids for Lower-Inflammation mRNA Vaccines
2026-09-11
The 2024 ACS Nano study developed mLNP-69, a lipid nanoparticle containing a low dose of mildronate-derived cationic lipid, to preserve mRNA delivery while reducing local inflammatory effects. In prophylactic and therapeutic B16OVA melanoma models, the formulation supported effective cancer-vaccine activity, providing a preclinical framework for separating delivery performance from lipid-associated inflammation.
-
Biotin-HPDP for Reversible Thiol Labeling
2026-09-11
Biotin-HPDP combines selective cysteine labeling, a cleavable disulfide linkage, and a spacer designed for efficient streptavidin detection. This article shows how to apply it to affinity purification, S-nitrosylation workflows, and mechanistic studies inspired by the HSD17B12–PD-L1 cancer-immunity axis.
-
SD 169: p38 Control for Translational Research
2026-09-10
SD 169 (indole-5-carboxamide) offers a focused way to interrogate p38α and p38β biology across inflammatory, metabolic, and neuroregenerative models. This article connects ATP-competitive kinase inhibition with emerging insights into activation-loop conformation, phosphatase access, and translational assay design.